During the past year, there was a frenzy to acquire drug assets aimed at the hepatitis C virus (HCV).

FORBES: Big Pharma Failures Light the Way to Change

Chronic infection with hepatitis C virus (HCV) is estimated to affect 170 million people worldwide, and more than five million in Europe.

BBC: Better treatment for Hepatitis C